v3 Template
D

DNA Nanobots

Biotechnology and Nanotechnology ~360 employees
Founded
--
Employees (Est.)
~360
18 leaders known
Total Funding
$3.5M
Funding Rounds
1
Last Funding
2025-12-17

About DNA Nanobots

DNA Nanobots, Inc. is a company focused on reshaping gene therapy and therapeutics delivery through innovative DNA nanotechnology. Their mission is to develop cutting-edge therapies and technologies to improve patient lives by creating safe and effective precision medicine solutions using their DNA nanoparticle platform.

Products & Services

Targeted Chemotherapies:Developing products for targeted delivery of chemotherapy drugs to minimize off-target effects.
Vaccines:Creating solutions for improved vaccine performance through tissue-specific targeting.
Point-of-Care Diagnostics:Offering diagnostic tools for rapid and precise health assessments.
Functionalized Gene Delivery:Providing non-viral delivery systems for gene therapy to enhance efficiency and specificity.
Custom DNA Nanostructures:Assisting in the design and deployment of custom DNA nanobots for targeted delivery of small molecules, proteins, peptides, or genes.
Biopharma Partner Program:Collaborating with companies to integrate DNA Nanobots' delivery technology with various therapeutics like chemotherapy drugs, siRNA, proteins, genes, or peptides.

Specialties

DNA Nanotechnology Gene Therapy Delivery Targeted Chemotherapies Precision Medicine Vaccine Development Custom DNA Nanostructures

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed 		A: 3500000
MR: -
FA: $3.5 million
FAN: 3500000 		D: 2025-12-17
FD: 2025-12-17 		1 investors
Seed Latest
2025-12-17
$3.5M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

James Lynch

Chief Executive Officer

LinkedIn (Pro only)
P

Patrick Halley

Chief Technology Officer

LinkedIn (Pro only)
C

Chris Lucas

Chief Science Officer

LinkedIn (Pro only)
L

Larry Beaver

Director of Finance

C

Carolyn Cheney

Senior Scientist

Q

Quincy Bizjak

Research Engineer - Process Development

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

DNA Nanobots Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology and Nanotechnology
Company Size
~360 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro